Glenmark Pharmaceuticals receives ANDA approval for Teriflunomide Tablets
Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (USFDA) for Teriflunomide Tablets, 7 mg and 14 mg, a generic version of Aubagio Tablets, 7 mg and 14 mg, of Sanofi-Aventis U.S., LLC. With respect to 180-day generic drug exclusivity, the company was one of the … Read more
